Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Earnings Preview: 10x Genomics
10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.
Analysts estimate that 10x Genomics will likely report an Earnings Per Share (EPS) of $-0.20
10x Genomics Earnings Preview
10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.
Analysts estimate that 10x Genomics will likely report an Earnings Per Share (EPS) of $-0.20
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Notable 10X Genomics Insider Trades $2.7M In Company Stock
Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing.
Why 10x Genomics Shares Are Trading Lower Today
10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target.
B of A Securities Downgrades 10x Genomics to Neutral, Announces $180 Price Target
B of A Securities analyst Derik De Bruin downgrades 10x Genomics (NASDAQ:TXG) from Buy to Neutral and announces $180 price target.
Looking into 10x Genomics’s Return on Capital Employed
Pulled from Benzinga Pro data 10x Genomics (NASDAQ:TXG) reported Q2 sales of $115.84 million. Earnings fell to a loss of $10.33 million, resulting in a 1.1% decrease from last quarter.